Investment professional Michael T. Jackson is a former resident of Belvedere, California. At the family based investment office SFG Asset Advisors, Mr. Jackson established and implemented hedged equity investment strategy. Michael T. Jackson has relocated from Belvedere to Florida and continued his philanthropic support for a variety of charitable organizations, including The Fledgling Fund.
As a non-profit organization that invests in creative media projects to bring lasting change, The Fledgling Fund operates around a vision set by its founder Diana Barrett. Her vision centers on a belief that well designed media projects can help vulnerable populations by educating groups and individuals about important social issues and encouraging mobilization.
In 2012, The Fledgling Fund contributed to an important film titled “Escape Fire: The Fight to Rescue American Healthcare”. The film examined the motives and money behind today’s medical system, one in which quick fixes are the norm and preventive approaches are minimized or dismissed.
“Escape Fire” was released at the Sundance Film Festival and received a number of awards. Subsequently, it premiered on CNN, drawing an audience of 2 million people. As the film’s message spread, a successful outreach and engagement campaign was launched. Through social media platforms and an interactive website, the campaign worked to continue the discussion at a national level and to encourage individuals and groups to take action.
The makers of “Escape Fire” succeeded in changing the health care discussion. Already, the film has been shown at over 700 screenings at universities across the country, and it is now offered as an option for nurses wishing to take continuing education classes. In addition, it is becoming a fixture in educational classes for medical professionals, community wellness organizations, and health care groups.
Michael T. Jackson, a former resident of Belvedere, California, is the founder of SFG Asset Advisors. In this position, Michael T. Jackson established and implemented hedged equity investment strategy. Since his relocation from Belvedere to Florida in 2002, Mr. Jackson has continued his work with charitable organizations such as the Napa Medical Research Foundation (NMRF).
Recently, the NMRF opened a new research lab facility that will help the organization continue its mission to discover and advance new treatments for orthopedics, rehabilitation, neurology, and sports medicine. Located in the Wellness Center in Napa, California, the lab was designed in conjunction with Ryan Dregalla, a biomedical laboratory consultant. The facility is outfitted with state-of-the-art equipment that includes a fluorescent microscope, flow cytometer, centrifuge, plate reader, and incubator. It will be used in conjunction with current and future studies that will ultimately benefit the medical community and patients who have musculoskeletal conditions.
At the lab facility, Dr. Marko Bodor will continue his promising research centering on the benefits of using platelet-rich plasma to treat a broad range of joint, tendon, bone, ligament, and spine conditions. In this type of treatment, researches are working to harness the therapeutic benefits of intracellular proteins by extracting them without damaging the protein or the platelet.
Michael T. Jackson, formerly of Belvedere, California, has worked for decades building an accomplished career in emerging markets and hedge funds. He established SFG Asset Advisors in 2001, and subsequently relocated from Belvedere to Florida. Throughout his career, Michael T. Jackson has demonstrated a passion for philanthropic work by supporting such initiatives as the founding of Napa Medical Research Foundation (NMRF).
NMRF regularly supports research exploring new treatments for disorders of the skeletal system and brain. The organization is currently participating in a number of research projects, including a study of greater trochanteric pain syndrome, or GTPS.
A condition typically found in both the elderly and middle-aged population, GTPS causes pain in the greater trochanter, which sits on the upper leg, near the hip joint. Individuals with this condition generally feel more intense pain after engaging in rigorous activity or lying on the afflicted area.
Through the support of NMRF, researchers have been able to hypothesize that tearing of the rotator cuff elicited the most persistent symptoms in GTPS patients. Therefore, scientists are looking to develop a treatment that involves the use of plasma platelets. When injected into the trochanter, this solution should help patients experience rapid healing and overcome their symptoms permanently.
This research has already elicited promising results. Between 80 percent and 90 percent of patients who received this experimental treatment saw an eradication of all their GTPS symptoms after a month. In the future, NMRF and its affiliate researchers hope to enlist the help of more patients for further trials.
A seasoned investor, philanthropist, and business leader, Michael T. Jackson is a former resident of Belvedere, California. Now residing in Florida, Michael T. Jackson leverages approximately 30 years of hedge fund and investment experience to guide young professionals with SFG Asset Advisors. Further, the former Belvedere resident is the founder of Napa Medical Research Foundation (NMRF), which conducts research into orthopedic regenerative healing.
One of NMRF’s most recent studies examined cervical facet arthritis, which most commonly affects individuals over the age of 50. Treatments for the condition generally involve injections of corticosteroids and biologic agents, such as plasma and bone marrow. In many cases, injections utilize fluoroscopic (x-ray) guidance. A time-consuming technique, fluoroscopically guided injections may have an accuracy rate of below 80 percent.
The study examined a new ultrasound-guided technique capable of delivering biologic agents to affected areas with greater accuracy sans radiation. Phase I trials have demonstrated the technique to be between 95 and 100 percent accurate. The data from the trial is now in the hands of a statistician, and the study’s findings are being prepared for publication.